Open AccessPB1760: AZACITIDINE AS TREATMENT OF KMT2A INFANT ACUTE LYMPHOBLASTIC LEUKEMIA: SINGLE CENTER EXPERIENCE
Author(s) -
Giagnuolo G.,
De Matteo A.,
Stellato P.,
Petruzziello F.,
Cuccurullo R.,
Beneduce G.,
Cacace F.,
Tambaro F. P.,
Parasole R.,
Menna G.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000849896.85988.6c
Subject(s) - medicine , azacitidine , minimal residual disease , oncology , etoposide , blinatumomab , chemotherapy , hematopoietic stem cell transplantation , gastroenterology , leukemia , transplantation , lymphoblastic leukemia , biochemistry , gene expression , chemistry , dna methylation , gene